Deregulation of microRNAs in myelodysplastic syndrome

G W Rhyasen1, D T Starczynowski

  • 1Department of Cancer and Cell Biology, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.

Leukemia
|August 20, 2011
PubMed

Insights

MicroRNAs (miRNAs) show unique expression patterns in myelodysplastic syndromes (MDS), impacting disease subtypes and outcomes. Understanding miRNA roles offers potential for novel MDS diagnostics and therapeutics.

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Myelodysplastic syndromes (MDS) are stem cell disorders with poor differentiation and high leukemia risk.
  • Current understanding of MDS pathogenesis and effective treatments remain limited.
  • Aberrant microRNA (miRNA) expression is increasingly implicated in MDS development.

Purpose of the Study:

  • To review miRNA expression profiles in MDS patients.
  • To associate miRNA expression with MDS subtypes and clinical outcomes.
  • To explore the role of miRNA deregulation in MDS mouse models.

Main Methods:

  • Review of published miRNA expression profiles in MDS.
  • Analysis of associations between miRNA patterns, MDS subtypes, and prognosis.
  • Examination of miRNA deregulation in preclinical MDS models.

Main Results:

  • Distinct miRNA expression signatures identified in MDS patients.
  • Specific miRNA patterns correlate with MDS subtypes and patient outcomes.
  • Mouse models demonstrate recapitulation of MDS features due to miRNA dysregulation.

Conclusions:

  • miRNAs are key players in MDS pathogenesis.
  • miRNA profiling holds potential for MDS diagnosis and prognosis.
  • Targeting miRNAs may offer new therapeutic strategies for MDS.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...